Dublin, April 20, 2026 (GLOBE NEWSWIRE)-- The "Viral Vector and Plasmid DNA Manufacturing Market (7th Edition): Industry Trends and Global Forecasts, till 2035" report has been added to ...

KING OF PRUSSIA, Pa., Jan. 18, 2023 /PRNewswire/ -- Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) dedicated to addressing critical challenges ...

Viral vectors are a key component of many advanced gene therapies and vaccines, but reliable, large-scale manufacturing remains a significant challenge. Continued innovation in vector design, cell ...

LONDON, Oct. 17, 2019 /PRNewswire/ -- Roots Analysis has announced the addition of "Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (3rd Edition), 2019-2030 (Focus on AAV, ...

Innovation in manufacturing technologies must occur to ensure the availability of gene therapies and cell therapies. The rapid advance of gene and modified cell therapies and growing interest in viral ...

There is intense focus on the prevention and control of viral contaminants during viral vector manufacturing, which is driving the need for more accurate and powerful analytical methods for detection.